SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 2, 2026

SEPN

Septerna, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago
Insider cluster: 2 insiders, $148K total
Actionable Insight • Neutral

This insider cluster is too small to warrant a trading signal. Monitor for upcoming pipeline catalysts (Septerna is a clinical-stage biotech) and any material 8-K or press release that could move the stock. The director grants are standard compensation and carry no directional implication.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$34.00
T+0 close · Jul 2, 2026 · via day close
Latest settled
+16.88%
T+60 · $39.74
Vs SPY
+13.31%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 6 $34.00entry
  2. T+1 · 4mo ago −1.56%α −2.43% · $33.47
  3. T+5 · 4mo ago +11.29%α +10.36% · $37.84
  4. T+20 · 4mo ago +3.47%α +3.89% · $35.18
  5. T+60 · 7w ago +16.88%α +13.31% · $39.74
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Septerna insiders (SVP Drug Discovery and Chief People Officer) sold a combined $148K in open-market shares after exercising options. The sales represent ~0.009% of the $1.6B market cap, trivial and consistent with routine tax/vesting-related transactions. No material signal for the stock.

Key Financial Metrics

Direction
selling
Total Value
$148.0K
Insiders
2

Key Facts

  • Total open-market sales: $148K (0.009% of $1.6B market cap)
  • Both sales occurred on the same day as option exercises (tax/vesting pattern)
  • 7 directors received non-cash stock grants on 2026-06-26 (no economic value)
  • Insider activity is routine and immaterial relative to company size

Financial Impact

Negligible, $148K in insider sales is less than 0.01% of market cap

Risk Factors

  • No material risk identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-SEPN-1783033258707

Track record

24 reports on SEPN

Performance horizon

7 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +55.96% at T+60 after the Apr 13, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry price pending
  2. Nov 12, 20263d ago 144 Neutral 3/10 Entry $42.60 Now $41.67 −2.18% settles Nov 20
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $42.60 Now $41.67 −2.18% settles Nov 20
  4. Nov 12, 20264d ago 144 Neutral 3/10 Entry $41.86 Now $41.67 −0.45% settles Nov 19
  5. Nov 9, 20267d ago Press Release Bearish 5/10 Entry $52.34 Now $41.67 +20.39% settles Nov 17
  6. Nov 4, 202612d ago 8-K Neutral 3/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
  7. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
  8. Sep 10, 20269w ago Press Release Neutral 2/10 Entry $38.51 to $38.69 Now $41.67 +8.21% ▲ +0.47% +0.69% vs SPY
  9. Sep 3, 202610w ago 3 Neutral 2/10 Entry $36.75 to $39.55 Now $41.67 +13.39% ▲ +7.62% +8.83% vs SPY
  10. Aug 25, 202611w ago 8-K Neutral 3/10 Entry $41.30 to $37.68 Now $41.67 +0.90% ▼ −8.77% −8.23% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 2, 2026